Long-Term Liabilities to Equity: invobioscience.com (INVO)

Stability generates high margins and a steady stream of free cash flow through the proprietary INVOcell system and a network of its own centers. Positive dynamics in the niche reproductive equipment segment are facilitating the expansion of sales geography and driving demand growth. This price chart, serving as the primary valuation tool with a metric of 2.76, complements data on partnerships with clinics to implement affordable innovations for INVO Bioscience, Inc. (INVO).

INVO Bioscience, Inc. (INVO) invests in complex supply chains for precision components of reproductive equipment. The financing of such capital-intensive processes is reflected in the ratio of liabilities with a maturity of over one year to equity. This metric measures the degree of financial leverage and the company's reliance on external borrowings. A decrease in this indicator reduces bankruptcy risk but may signal stagnant development. By analyzing the dynamics of long-term loans to equity, an investor assesses the balance between stability and expansion.